INVESCO BIOTECHNOLOGY & GENOME ETF(PBE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PBE INVESCO BIOTECHNOLOGY & GENOME ETF

交易中 07-08 13:23:21 EDT

91.90

-1.28

-1.37%

最高93.04	最低91.90	成交量3,708
今开92.72	昨收93.18	日振幅1.22%
总市值2.84亿	流通市值2.84亿	总股本309.00万
成交额34.19万	换手率0.12%	流通股本309.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":91.9,"timestamp":1783531191074,"preClose":93.18,"halted":0,"volume":3708,"delay":0,"changeRate":-0.013736853402017612,"floatShares":3090000,"shares":3090000,"eps":1.793292,"marketStatus":"交易中","change":-1.28,"latestTime":"07-08 13:23:21 EDT","open":92.72,"high":93.04,"low":91.9,"amount":341893.76687999995,"amplitude":0.012234,"askPrice":92.39,"askSize":900,"bidPrice":92.13,"bidSize":200,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1783540800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":93.18,"sharesOutstanding":3180000,"nav":91.90231,"aum":286735207.2,"dividendRate":0.016831,"bidAskSpread":0.002232,"postHourTrading":{"tag":"盘后","latestPrice":93.18,"preClose":93.18,"latestTime":"16:10 EDT","volume":12,"amount":1117.22,"timestamp":1783455004468,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.390976,"impliedVol":0.1981,"impliedVolPercentile":0.6733},"requestUrl":"/m/hq/s/PBE","defaultTab":"news","newsList":[{"id":"2649299398","title":"大摩解读福泰制药百亿收购Crinetics：补齐内分泌管线布局 两大核心药物打开增长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2649299398","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649299398?lang=zh_cn&edition=full","pubTime":"2026-07-08 20:01","pubTimestamp":1783512080,"startTime":"0","endTime":"0","summary":"摩根士丹利发布研报，对福泰制药以100亿美元收购Crinetics的交易进行解读。此次收购将为福泰制药新增第五大业务支柱——内分泌药物，补齐公司管线布局。根据公告，每股85美元的收购价格较Crinetics周一的收盘价溢价了102%。值得注意的是，摩根士丹利担任福泰制药的财务顾问，协助该公司达成收购Crinetics的协议。","market":"us","thumbnail":"https://community-static.tradeup.com/news/7870ada20f73cf52a4a0efa576cd369c","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/7870ada20f73cf52a4a0efa576cd369c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464871.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"大摩解读福泰制药(VRTX.US)百亿收购Crinetics：补齐内分泌管线布局 两大核心药物打开增长空间","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2362541273.HKD","BBH","LU0079474960.USD","IE0002141913.USD","LU0882574139.USD","KBWB","LU1732799900.SGD","LU0210528500.USD","IE00B19Z9P08.USD","LU0058720904.USD","LU1363072403.SGD","LU2487616109.SGD","IE00BZ9MQY76.HKD","LU2111349929.HKD","IAI","IE0009355771.USD","LU2237438978.USD","LU1720051017.SGD","LU0053666078.USD","LU0528227936.USD","LU2089284900.SGD","LU1791710400.SGD","IE00B19Z3581.USD","BK4581","LU0823416689.USD","IBBQ","IE0002270589.USD","LU0109394709.USD","LU2133065610.SGD","LU2362540622.SGD","LU2456880835.USD","IE00B894F039.SGD","IBB","LU1720051108.HKD","LU0267386448.USD","LU1585245621.USD","LU1674673691.USD","LU0432979614.USD","BK4533","SG9999001176.USD","LU1244550221.USD","LU0098860793.USD","VRTX","BK4139","IDNA","LU2236285917.USD","BK4588","BIB","LU0390134368.USD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649939579","title":"大摩解读福泰制药(VRTX.US)百亿收购Crinetics：补齐内分泌管线布局 两大核心药物打开增长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2649939579","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649939579?lang=zh_cn&edition=full","pubTime":"2026-07-08 19:40","pubTimestamp":1783510856,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1430594728.SGD","LU2347655156.SGD","LU1074936037.SGD","SG9999001176.USD","LU0053666078.USD","LU1244550221.USD","LU0795875086.SGD","LU1585245621.USD","PBE","LU2237438978.USD","SG9999013999.USD","IE00B19Z9Z06.USD","IDNA","LU1548497426.USD","LU0314104364.USD","LU0061475181.USD","BK4567","LU0882574139.USD","IBB","BK4127","LU2362540622.SGD","IE00B19Z3581.USD","LU1720051017.SGD","LU0795875169.SGD","BK4139","KBWB","SG9999001176.SGD","LU1244550577.SGD","LU0006306889.USD","LU0823416689.USD","LU1674673428.USD","BBH","IE00B19Z3B42.SGD","LU0417517546.SGD","LU2089283258.USD","LU0079474960.USD","LU2271345857.HKD","LU0058720904.USD","IE00BJJMRZ35.SGD","LU2133065610.SGD","BIB","IBBQ","VRTX","LU2487616109.SGD","LU2417539215.USD","LU2462157665.USD","IAI","LU2362541273.HKD","LU1668664300.SGD","LU0267386448.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649969921","title":"RBC Capital上调福泰制药目标价至570美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649969921","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649969921?lang=zh_cn&edition=full","pubTime":"2026-07-08 16:24","pubTimestamp":1783499090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2417539215.USD","VRTX","LU1778281490.HKD","IE00B2B36J28.USD","LU0029864427.USD","UDN","LU1093756168.USD","BK4567","SG9999001176.USD","BIB","BK4207","IE00B894F039.SGD","SGXZ57979304.SGD","BK4532","LU2456880835.USD","LU0708994859.HKD","IDNA","IE0009355771.USD","BK4139","LU0128525929.USD","RY","LU1069344957.HKD","LU0320765992.SGD","LU2462157665.USD","LU0823416689.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0234570918.USD","IE00B4R5TH58.HKD","LU1267930573.SGD","PBE","LU0417517546.SGD","LU2324357040.USD","LU0058720904.USD","UUP","SG9999013999.USD","BBH","IE00BFTCPJ56.SGD","BK4585","IE00BJJMRZ35.SGD","BK4533","GSIB","IBBQ","IE00B19Z9P08.USD","LU1093756325.SGD","LU2237438978.USD","LU2362540622.SGD","LU0310800379.SGD","IBB","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649952006","title":"（活力中国调研行）上海生物医药产业规模破万亿 张江药谷青年人才成创新药研发主力","url":"https://stock-news.laohu8.com/highlight/detail?id=2649952006","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649952006?lang=zh_cn&edition=full","pubTime":"2026-07-08 11:56","pubTimestamp":1783482969,"startTime":"0","endTime":"0","summary":"中新网上海7月8日电(杨海燕马佳佳)“我们对青年人才‘如饥似渴’，上海团队有180多名全职员工，90%以上都是40岁以下的青年人才。”英硅智能全球对外合作负责人、副总裁王珏7日在“活力中国调研行”主题采访活动中介绍道。在上海张江药谷，这片曾经的农田已崛起为世界级生物医药创新高地，而活跃其中的青年人才，正成为推动创新药研发的主力军。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607083798154946.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607083798154946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["161726","PBE","BBP","XBI","BK4581","BK4585","IBB","LFSC","SBIO","GSKH","WRND","GDOC","399441","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111378876","title":"Vera Therapeutics股价飙升：肾病新药获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1111378876","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111378876?lang=zh_cn&edition=full","pubTime":"2026-07-08 02:47","pubTimestamp":1783450047,"startTime":"0","endTime":"0","summary":"周二，Vera Therapeutics, Inc.的股价上涨约8%，此前美国食品药品监督管理局批准了其用于治疗IgA肾病的药物。这款名为Trutakna的药物通过阻断两种蛋白质来发挥作用，这两种蛋白质会促使免疫系统产生抗体，这些抗体在肾脏中积聚并造成损伤。这是美国首个获批同时靶向这两种蛋白质的药物，尽管已有其他几种药物治疗该疾病。福泰制药正在研发一种同样能阻断这两种蛋白质的类似药物，FDA预计将在今年晚些时候对此做出裁决。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","LU2362540622.SGD","LU0058720904.USD","LU0417517546.SGD","IE0009355771.USD","LU0823416689.USD","LU2362541273.HKD","SGXZ57979304.SGD","IBBQ","BK4533","LU2456880835.USD","IE00B19Z3581.USD","LU2362541513.USD","SG9999013999.USD","LU0289739699.SGD","BK4539","IE00B2B36J28.USD","LU1093756325.SGD","SG9999001176.SGD","IE0002270589.USD","LU1430594728.SGD","IDNA","BIB","LU1674673691.USD","LU2462157665.USD","LABU","LU2237438978.USD","IE00BJJMRZ35.SGD","IE00BZ9MQY76.HKD","IE00B19Z9Z06.USD","LU1069344957.HKD","LU1585245621.USD","IE00BJT1NW94.SGD","VERA","LU0432979614.USD","BK4532","IE0002141913.USD","LU1035775433.USD","LU1093756168.USD","IE00B4R5TH58.HKD","IE00B19Z9P08.USD","LU1778281490.HKD","BK4567","PBE","BK4588","LU0889565916.HKD","IE00B19Z3B42.SGD","IE00BFTCPJ56.SGD","LU0256863811.USD","LU0061475181.USD","IBB","BK4585","LU1674673428.USD","VRTX","LU0109394709.USD","LU0234570918.USD","BBH","LU2417539215.USD","BK4139","LU0320765992.SGD","LU2324357040.USD","LU0079474960.USD","SG9999001176.USD","IE00B894F039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984355","title":"翰思艾泰-B(03378)：拟与华科前沿交叉研究中心打造新一代AI驱动的创新药研发范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984355","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649984355?lang=zh_cn&edition=full","pubTime":"2026-07-07 18:57","pubTimestamp":1783421872,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B 发布公告，为充分发挥产学研结合的优势，加速生物医药研发创新，公司于近日与华科—澳城大高等研究院前沿交叉研究中心正式签署了《“人工智能药物研发联合实验室”合作共建协议》。双方将依托华科前沿交叉研究中心的AI平台，以及翰思艾泰在创新药研发的丰富经验和对疾病领域的深度认知，围绕抗体发现与分子设计展开深度合作，共同打造新一代AI驱动的创新药研发范式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["QTOC","SBIO","CHAT","WRND","GDOC","BK1161","BK1173","AIPO","IBB","BK1535","ARTY","BK4585","03378","LFSC","GSKH","PBE","AGIX","BK4588","BBP","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649708736","title":"100亿美元砸出史上最大收购：福泰制药(VRTX.US)溢价100%收购Crinetics(CRNX.US)，杀入内分泌赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2649708736","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649708736?lang=zh_cn&edition=full","pubTime":"2026-07-07 08:35","pubTimestamp":1783384535,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1035775433.USD","LU0058720904.USD","BBH","PBE","LU1430594728.SGD","LU0079474960.USD","LU2417539215.USD","LU1778281490.HKD","LU0320765992.SGD","LU0889565916.HKD","LU2362540622.SGD","IBB","LU0109394709.USD","BIB","LU0432979614.USD","IE00BJJMRZ35.SGD","IE0002270589.USD","LU2237438978.USD","BK4139","IE00B2B36J28.USD","LU0061475181.USD","IE00BJT1NW94.SGD","LU2362541273.HKD","IDNA","SG9999001176.USD","LU2456880835.USD","SGXZ57979304.SGD","LU0823416689.USD","LU1674673691.USD","CRNX","LU2324357040.USD","BK4585","BK4588","IE00B19Z3581.USD","LU0289739699.SGD","LU0256863811.USD","LU1093756168.USD","LU1093756325.SGD","SG9999001176.SGD","LU0417517546.SGD","IE00B4R5TH58.HKD","LU0234570918.USD","LU1585245621.USD","BK4007","VRTX","IBBQ","IE00BZ9MQY76.HKD","IE00B19Z9P08.USD","BK4533","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159544198","title":"SEC文件披露：特定情况下交易终止，Crinetics Pharmaceuticals或需向福泰制药支付3.5047亿美元解约费","url":"https://stock-news.laohu8.com/highlight/detail?id=1159544198","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159544198?lang=zh_cn&edition=full","pubTime":"2026-07-07 05:22","pubTimestamp":1783372928,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件披露，Crinetics Pharmaceuticals Inc. 与福泰制药之间的交易若在特定情况下被终止，前者可能需要向后者支付高达3.5047亿美元的终止费用。该文件明确了触发这一巨额财务义务的具体情形。协议条款显示，这笔费用的支付并非自动生效，而是与特定的终止条件紧密挂钩。然而，这也同时意味着，一旦协议因规定情形破裂，Crinetics Pharmaceuticals将面临显著的财务支出。目前，市场正密切关注两家公司后续的动向以及该交易的具体进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","IE00B19Z3B42.SGD","LU0432979614.USD","LU0889565916.HKD","VRTX","LU0079474960.USD","CRNX","LU0256863811.USD","LU1778281490.HKD","LU2236285917.USD","LU2417539215.USD","BK4007","IDNA","LU1585245621.USD","IE00BJT1NW94.SGD","BK4139","LU1069344957.HKD","LU1674673428.USD","LU2362541513.USD","LU2456880835.USD","IE00B4R5TH58.HKD","LU0234570918.USD","LU1093756325.SGD","LU2362540622.SGD","LU2237438978.USD","PBE","LU0109394709.USD","SG9999013999.USD","LU0320765992.SGD","LU1035775433.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","LU0417517546.SGD","LU0823416689.USD","BK4533","BK4567","LU0061475181.USD","IE0002270589.USD","IE0002141913.USD","BK4532","IE00B2B36J28.USD","IE00B19Z9P08.USD","SG9999001176.USD","BIB","LU2362541273.HKD","IE00B894F039.SGD","IBBQ","IE00BJJMRZ35.SGD","IE00B19Z9Z06.USD","BBH","IE00BZ9MQY76.HKD","IE0009355771.USD","LU1674673691.USD","LU1430594728.SGD","BK4585","LU1093756168.USD","IBB","LU0058720904.USD","LU2462157665.USD","SG9999001176.SGD","BK4588","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679149","title":"生物制药公司Crinetics盘后涨超100%福泰制药将以85美元/股收购公司。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649679149?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:09","pubTimestamp":1783368555,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B19Z9P08.USD","IE00BJT1NW94.SGD","BK4532","SG9999001176.USD","LU2362541513.USD","BBH","IE0002141913.USD","IE00B19Z3581.USD","BBP","LU0289739699.SGD","PBE","BIB","BK4588","BK4567","LU2417539215.USD","UUP","SGXZ57979304.SGD","LU0823416689.USD","LU1035775433.USD","IE00BFTCPJ56.SGD","MRNX","LU1093756168.USD","LU0320765992.SGD","BK4585","VRTX","BK4139","IBB","IE00B19Z9Z06.USD","BK4533","LU1093756325.SGD","MRNY","UDN","LU2324357040.USD","LU1778281490.HKD","LU1585245621.USD","SG9999013999.USD","LU2236285917.USD","LU2456880835.USD","LU2462157665.USD","LU2237438978.USD","LU1674673428.USD","IDNA","LU2362541273.HKD","LU0079474960.USD","LU1674673691.USD","IE00BJJMRZ35.SGD","LU2362540622.SGD","LU0061475181.USD","IE00B2B36J28.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127833937","title":"Crinetics与福泰制药交易预计2029年提升后者非GAAP运营收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1127833937","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127833937?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:07","pubTimestamp":1783368452,"startTime":"0","endTime":"0","summary":"根据最新披露的财务预测，Crinetics Pharmaceuticals Inc. 与福泰制药达成的战略合作，预计将在2029年对福泰制药的非通用会计准则运营收入产生积极贡献。\n此次交易的结构设计旨在通过长期协同效应，增强福泰制药的盈利质量。分析指出，该合作不仅将拓展福泰制药在特定治疗领域的产品管线，还可能优化其整体运营效率。市场预期，随着合作项目进入成熟阶段，其对财务指标的正面影响将逐步显现。\n财务模型显示，此次合作带来的收入增长与成本协同效应，是推动非通用会计准则运营收入提升的关键因素。投资者正密切关注交易细节及后续整合进程，以评估其长期价值创造潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0432979614.USD","LU2324357040.USD","IBBQ","BK4532","IE0002141913.USD","LU1093756325.SGD","IE0009355771.USD","LU1035775433.USD","LU1069344957.HKD","IE00B4R5TH58.HKD","SG9999013999.USD","IE00B894F039.SGD","LU1093756168.USD","LU1778281490.HKD","VRTX","IE00BJJMRZ35.SGD","LU0109394709.USD","LU1430594728.SGD","SGXZ57979304.SGD","LU2236285917.USD","BK4139","IE0002270589.USD","LU1674673428.USD","LU0058720904.USD","LU2362541513.USD","LU2417539215.USD","IE00B19Z3B42.SGD","BK4533","BK4567","LU2362541273.HKD","LU0079474960.USD","LU0256863811.USD","IE00B19Z3581.USD","IE00B19Z9P08.USD","LU1674673691.USD","SG9999001176.USD","LU2462157665.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","LU0234570918.USD","LU0889565916.HKD","IE00BZ9MQY76.HKD","LU2362540622.SGD","SG9999001176.SGD","IBB","BBH","LU2456880835.USD","LU1585245621.USD","BIB","LU0417517546.SGD","LU0289739699.SGD","LU2237438978.USD","IE00B19Z9Z06.USD","LU0061475181.USD","BK4585","PBE","IDNA","LU0823416689.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4588","CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179291339","title":"Crinetics Pharmaceuticals：融资获美国银行与摩根士丹利的45亿美元全额承诺过桥贷款支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1179291339","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179291339?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:06","pubTimestamp":1783368378,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc. 的融资计划，已获得来自美国银行和摩根士丹利高级融资部门提供的总额高达45亿美元的全额承诺过桥贷款支持。这笔资金将为公司的战略推进提供坚实的财务后盾。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001176.SGD","IE00B19Z3B42.SGD","IE00B19Z9Z06.USD","IE00B2B36J28.USD","LU1674673428.USD","BK4533","LU2362540622.SGD","LU1430594728.SGD","LU2324357040.USD","IE00B4R5TH58.HKD","LU0432979614.USD","LU2462157665.USD","LU2362541513.USD","LU0320765992.SGD","IE00B19Z3581.USD","LU2237438978.USD","LU0823416689.USD","IE00B19Z9P08.USD","LU0234570918.USD","IE00BFTCPJ56.SGD","IBB","IE00BZ9MQY76.HKD","IBBQ","SG9999001176.USD","LU1093756168.USD","IE0009355771.USD","LU0079474960.USD","LU1093756325.SGD","LU2236285917.USD","SG9999013999.USD","BK4585","SGXZ57979304.SGD","BK4007","LU0058720904.USD","BK4588","BBH","LU2456880835.USD","IE00BJT1NW94.SGD","LU1069344957.HKD","BK4139","LU0417517546.SGD","LU0289739699.SGD","PBE","IE0002141913.USD","CRNX","IE0002270589.USD","IE00B894F039.SGD","LU0061475181.USD","LU0889565916.HKD","LU1778281490.HKD","LU2362541273.HKD","BK4532","LU1585245621.USD","LU2417539215.USD","LU1674673691.USD","BIB","BK4567","LU1035775433.USD","LU0256863811.USD","VRTX","LU0109394709.USD","IDNA","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154393441","title":"福泰制药就囊性纤维化疗法Alyftrek与泛加拿大药品联盟签署意向书","url":"https://stock-news.laohu8.com/highlight/detail?id=1154393441","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154393441?lang=zh_cn&edition=full","pubTime":"2026-07-06 22:25","pubTimestamp":1783347947,"startTime":"0","endTime":"0","summary":"福泰制药与泛加拿大药品联盟就囊性纤维化治疗药物Alyftrek的潜在合作签署了意向书。此举标志着该药物在加拿大市场准入进程中的一个重要步骤，旨在为患者提供新的治疗选择。意向书的签署为后续正式协议的谈判奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","SG9999001176.USD","LU0823416689.USD","LU2237438978.USD","LU2462157665.USD","IBB","IE00B19Z9P08.USD","BK4139","LU1035775433.USD","PBE","BK4585","IBBQ","LU1778281490.HKD","IE00B4R5TH58.HKD","LU2324357040.USD","SG9999001176.SGD","BK4588","LU0234570918.USD","LU0109394709.USD","LU0058720904.USD","IE00B894F039.SGD","IE00B2B36J28.USD","LU0889565916.HKD","LU0417517546.SGD","IE00B19Z3B42.SGD","VRTX","LU0079474960.USD","LU0256863811.USD","LU1430594728.SGD","LU2362540622.SGD","LU2362541513.USD","LU2362541273.HKD","LU1585245621.USD","BK4567","BK4532","LU0320765992.SGD","LU1069344957.HKD","LU1674673428.USD","SG9999013999.USD","IE00B19Z3581.USD","LU2236285917.USD","LU2456880835.USD","BBH","IE00BJT1NW94.SGD","LU2417539215.USD","IE0002270589.USD","IE00B19Z9Z06.USD","IDNA","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","LU0432979614.USD","IE0002141913.USD","LU0289739699.SGD","IE00BZ9MQY76.HKD","IE00BFTCPJ56.SGD","LU1674673691.USD","LU1093756325.SGD","IE0009355771.USD","BIB","LU0061475181.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617393586","title":"Picocela Inc盘中异动 早盘股价大涨5.60%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617393586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617393586?lang=zh_cn&edition=full","pubTime":"2026-03-06 23:08","pubTimestamp":1772809680,"startTime":"0","endTime":"0","summary":"北京时间2026年03月06日23时08分，Picocela Inc股票出现异动，股价大幅上涨5.60%。截至发稿，该股报3.14美元/股，成交量1581股，换手率0.04%，振幅0.67%。Picocela Inc股票所在的电信服务行业中，整体跌幅为0.68%。其相关个股中，Picocela Inc、Veon Ltd、Surgepays, Inc.涨幅较大，Veon Ltd、Elauwit Connection, Inc.、回声星通信较为活跃，换手率分别为0.37%、0.23%、0.21%，振幅较大的相关个股有Veon Ltd、Picocela Inc、Fingermotion, Inc.，振幅分别为13.54%、7.95%、5.68%。Picocela Inc公司简介：PicoCELA Inc专注于制造、安装和服务企业无线网络解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030623080095439af7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030623080095439af7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4020","PBE","PCLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614700788","title":"Picocela Inc盘中异动 早盘急速上涨5.38%报4.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614700788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614700788?lang=zh_cn&edition=full","pubTime":"2026-02-24 23:49","pubTimestamp":1771948141,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日23时49分，Picocela Inc股票出现异动，股价大幅拉升5.38%。截至发稿，该股报4.85美元/股，成交量5628股，换手率0.14%，振幅7.60%。Picocela Inc股票所在的电信服务行业中，整体涨幅为0.48%。其相关个股中，Sify Technologies Limited、Surgepays, Inc.、铱星通讯涨幅较大，Cogent通信、Iothree Limited、Cable One, Inc.较为活跃，换手率分别为0.72%、0.68%、0.61%，振幅较大的相关个股有Sify Technologies Limited、Cable One, Inc.、Surgepays, Inc.，振幅分别为10.68%、8.22%、7.65%。Picocela Inc公司简介：PicoCELA Inc专注于制造、安装和服务企业无线网络解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224234901a4c39c8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224234901a4c39c8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCLA","BK4020","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609835135","title":"Picocela Inc盘中异动 股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609835135","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609835135?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:38","pubTimestamp":1770302300,"startTime":"0","endTime":"0","summary":"北京时间2026年02月05日22时38分，Picocela Inc股票出现波动，股价快速跳水5.12%。截至发稿，该股报5.74美元/股，成交量4501股，换手率0.11%，振幅4.13%。Picocela Inc股票所在的电信服务行业中，整体涨幅为0.25%。其相关个股中，优克联、Tim S.A.、Gogo Inc.涨幅较大，Iqstel Inc.、Iothree Limited、铱星通讯较为活跃，换手率分别为1.01%、0.43%、0.16%，振幅较大的相关个股有Elauwit Connection, Inc.、Iqstel Inc.、Picocela Inc，振幅分别为12.23%、8.50%、4.30%。Picocela Inc公司简介：PicoCELA Inc专注于制造、安装和服务企业无线网络解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020522382095400225&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020522382095400225&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBE","BK4020","PCLA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0394},{"period":"1month","weight":0.1162},{"period":"3month","weight":0.1615},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.4439},{"period":"ytd","weight":0.1343}],"compareEarnings":[{"period":"1week","weight":0.0013},{"period":"1month","weight":0.0138},{"period":"3month","weight":0.1061},{"period":"6month","weight":0.0844},{"period":"1year","weight":0.2047},{"period":"ytd","weight":0.0965}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.018649},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.004391},{"month":3,"riseRate":0.47619,"avgChangeRate":-0.002718},{"month":4,"riseRate":0.52381,"avgChangeRate":0.005803},{"month":5,"riseRate":0.619048,"avgChangeRate":0.008753},{"month":6,"riseRate":0.666667,"avgChangeRate":0.018605},{"month":7,"riseRate":0.681818,"avgChangeRate":0.040548},{"month":8,"riseRate":0.571429,"avgChangeRate":0.007712},{"month":9,"riseRate":0.380952,"avgChangeRate":-0.012976},{"month":10,"riseRate":0.52381,"avgChangeRate":-0.006664},{"month":11,"riseRate":0.714286,"avgChangeRate":0.035033},{"month":12,"riseRate":0.47619,"avgChangeRate":0.000122}],"exchange":"ARCA","name":"INVESCO BIOTECHNOLOGY & GENOME ETF","nameEN":"INVESCO BIOTECHNOLOGY & GENOME ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INVESCO BIOTECHNOLOGY & GENOME ETF(PBE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供INVESCO BIOTECHNOLOGY & GENOME ETF(PBE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"INVESCO BIOTECHNOLOGY & GENOME ETF,PBE,INVESCO BIOTECHNOLOGY & GENOME ETF股票,INVESCO BIOTECHNOLOGY & GENOME ETF股票老虎,INVESCO BIOTECHNOLOGY & GENOME ETF股票老虎国际,INVESCO BIOTECHNOLOGY & GENOME ETF行情,INVESCO BIOTECHNOLOGY & GENOME ETF股票行情,INVESCO BIOTECHNOLOGY & GENOME ETF股价,INVESCO BIOTECHNOLOGY & GENOME ETF股市,INVESCO BIOTECHNOLOGY & GENOME ETF股票价格,INVESCO BIOTECHNOLOGY & GENOME ETF股票交易,INVESCO BIOTECHNOLOGY & GENOME ETF股票购买,INVESCO BIOTECHNOLOGY & GENOME ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INVESCO BIOTECHNOLOGY & GENOME ETF(PBE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供INVESCO BIOTECHNOLOGY & GENOME ETF(PBE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}